Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

Income Statement

Thermo Fisher Scientific Inc., consolidated income statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Product revenues 25,243 28,548 30,361 25,306 19,496
Service revenues 17,614 16,367 8,850 6,912 6,046
Revenues 42,857 44,915 39,211 32,218 25,542
Cost of product revenues (13,168) (14,247) (13,594) (11,407) (10,037)
Cost of service revenues (12,589) (11,697) (5,979) (4,807) (4,177)
Cost of revenues (25,757) (25,944) (19,573) (16,214) (14,214)
Gross profit 17,100 18,971 19,638 16,004 11,328
Selling, general and administrative expenses (8,445) (8,993) (8,007) (6,930) (6,144)
Research and development expenses (1,337) (1,471) (1,406) (1,181) (1,003)
Restructuring and other income (costs) (459) (114) (197) (99) 413
Operating income 6,859 8,393 10,028 7,794 4,594
Interest income 879 272 43 65 224
Interest expense (1,375) (726) (536) (553) (676)
Other income (expense) (65) (104) (694) (76) (70)
Income before income taxes 6,298 7,835 8,841 7,230 4,072
Provision for income taxes (284) (703) (1,109) (850) (374)
Equity in losses of unconsolidated entities (59) (172) (4) (3)
Net income 5,955 6,960 7,728 6,377 3,698
Net (income) losses attributable to noncontrolling interests and redeemable noncontrolling interest 40 (10) (3) (2) (2)
Net income attributable to Thermo Fisher Scientific Inc. 5,995 6,950 7,725 6,375 3,696

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Income statement item Description The company
Revenues Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Thermo Fisher Scientific Inc. revenues increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Operating income The net result for the period of deducting operating expenses from operating revenues. Thermo Fisher Scientific Inc. operating income decreased from 2021 to 2022 and from 2022 to 2023.
Income before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Thermo Fisher Scientific Inc. income before income taxes decreased from 2021 to 2022 and from 2022 to 2023.
Net income attributable to Thermo Fisher Scientific Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Thermo Fisher Scientific Inc. net income attributable to Thermo Fisher Scientific Inc. decreased from 2021 to 2022 and from 2022 to 2023.